Selected article for: "acute infection and confirm case"
Author: Nespola, Martina; Sirignano, Pasqualino; Fermani, Nicoletta; Battocchio, Cesare; Tosti, Filomena; Pranteda, Chiara; Taurino, Maurizio
Title: Treatment-resistant acute upper limb ischemia in a patient with Systemic Lupus Erythematous and concomitant SARS-CoV-2 infection: a case report.
  • Cord-id: 6m3y032i
  • Document date: 2021_6_25
    • ID: 6m3y032i
    Snippet: To describe the case of a young female patient, affected by Systemic Lupus Erythematous, hospitalized for severe SARS-CoV-2 infection pneumonia and presenting a treatment-resistant acute upper limb ischemia. Two days after hospital admission, the patient suffered sudden right upper limb pain associated with mild functional impairment. At physical examination, radial and ulnar pulses were absent, and no flow signal was detected at duplex ultrasound scan. Therefore, an acute limb ischemia diagnose
    Document: To describe the case of a young female patient, affected by Systemic Lupus Erythematous, hospitalized for severe SARS-CoV-2 infection pneumonia and presenting a treatment-resistant acute upper limb ischemia. Two days after hospital admission, the patient suffered sudden right upper limb pain associated with mild functional impairment. At physical examination, radial and ulnar pulses were absent, and no flow signal was detected at duplex ultrasound scan. Therefore, an acute limb ischemia diagnoses was posed. Despite several surgical and endovascular revascularization attempts, the patient underwent an above the elbow amputation in 10(th) postoperative day from first surgical embolectomy, and she died for respiratory failure 25 days after hospitalization. Our case of acute upper limb ischemia seems to confirm that clinical manifestation and fate of thrombotic disorder in COVID-19 patients could be precipitated by concomitant autoimmune diseases.

    Search related documents:
    Co phrase search for related documents
    • abnormal aptt and acute respiratory syndrome: 1
    • abnormal aptt and lupus anticoagulant: 1
    • abnormal clotting and acute respiratory syndrome: 1, 2
    • acute occlusion and low molecular weight heparin: 1
    • acute respiratory syndrome and additional monitoring: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory syndrome and adjuvant therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low molecular weight heparin prophylactic therapy: 1, 2, 3
    • acute respiratory syndrome and lupus anticoagulant: 1, 2, 3, 4, 5, 6, 7
    • acute upper limb and low molecular weight heparin: 1, 2
    • acute upper limb ischemia and low molecular weight heparin: 1, 2
    • adjuvant therapy and low molecular weight heparin: 1, 2, 3, 4
    • low molecular weight heparin and lupus anticoagulant: 1, 2, 3, 4, 5